These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20831989)

  • 1. Batroxobin for prevention of restenosis in diabetic patients after infrapopliteal arterial angioplasty: a small randomized pilot trial.
    Wang J; Zhu YQ; Liu F; Li MH; Zhao JG; Tan HQ; Wang JB; Cheng YS; Zhang PL
    Ann Vasc Surg; 2010 Oct; 24(7):876-84. PubMed ID: 20831989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
    Wang J; Zhu YQ; Li MH; Zhao JG; Tan HQ; Wang JB; Liu F; Cheng YS
    J Vasc Interv Radiol; 2011 Jul; 22(7):987-94. PubMed ID: 21570870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subintimal angioplasty for below-the-ankle arterial occlusions in diabetic patients with chronic critical limb ischemia.
    Zhu YQ; Zhao JG; Liu F; Wang JB; Cheng YS; Li MH; Wang J; Li J
    J Endovasc Ther; 2009 Oct; 16(5):604-12. PubMed ID: 19842730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty.
    Salapura V; Blinc A; Kozak M; Jezovnik MK; Pohar Perme M; Berden P; Kuhelj D; Kljucevsek T; Popovic P; Stankovic M; Vrtovec M; Surlan M
    Vasa; 2010 May; 39(2):159-68. PubMed ID: 20464672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runoff detected by magnetic resonance angiography as an indicator for better recanalization outcomes in below-the-knee chronic total occlusions in diabetic patients.
    Zhu YQ; Wang J; Tan HQ; Lu HT; Liu F; Cheng YS; Wei LM; Zhang PL; Zhao JG
    J Endovasc Ther; 2015 Apr; 22(2):243-51. PubMed ID: 25809370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.
    Bosiers M; Scheinert D; Peeters P; Torsello G; Zeller T; Deloose K; Schmidt A; Tessarek J; Vinck E; Schwartz LB
    J Vasc Surg; 2012 Feb; 55(2):390-8. PubMed ID: 22169682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary use of sirolimus-eluting stents in the infrapopliteal arteries.
    Rastan A; Schwarzwälder U; Noory E; Taieb FH; Beschorner U; Sixt S; Bürgelin K; Amantea P; Neumann FJ; Zeller T
    J Endovasc Ther; 2010 Aug; 17(4):480-7. PubMed ID: 20681763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study.
    Liistro F; Angioli P; Porto I; Ricci L; Ducci K; Grotti S; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2014 Feb; 21(1):1-8. PubMed ID: 24502477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease.
    Schmidt A; Ulrich M; Winkler B; Klaeffling C; Bausback Y; Bräunlich S; Botsios S; Kruse HJ; Varcoe RL; Kum S; Scheinert D
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1047-54. PubMed ID: 20518006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosis.
    Werner M; Scheinert D; Henn M; Scheinert S; Bräunlich S; Bausback Y; Friedenberger J; Schuster J; Hertting K; Piorkowski M; Rosner C; Schmidt A; Ulrich M; Gutberlet M
    J Endovasc Ther; 2012 Aug; 19(4):467-75. PubMed ID: 22891824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.
    Karnabatidis D; Spiliopoulos S; Diamantopoulos A; Katsanos K; Kagadis GC; Kakkos S; Siablis D
    J Endovasc Ther; 2011 Feb; 18(1):1-12. PubMed ID: 21314342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical predictors of major adverse limb events after infrapopliteal angioplasty for patients with critical limb ischaemia due to pure isolated infrapopliteal lesions.
    Iida O; Soga Y; Yamauchi Y; Hirano K; Kawasaki D; Tazaki J; Yamaoka T; Suematsu N; Suzuki K; Shintani Y; Miyashita Y; Takahara M; Uematsu M
    Eur J Vasc Endovasc Surg; 2012 Sep; 44(3):318-24. PubMed ID: 22682012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
    Radak Dj; Laps KH; Jeger KA; Ilijevski N; Vojić M
    Srp Arh Celok Lek; 1998; 126(3-4):83-91. PubMed ID: 9863361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-related outcomes in the endovascular treatment of infrainguinal arterial obstructive disease.
    Pulli R; Dorigo W; Pratesi G; Fargion A; Angiletta D; Pratesi C
    J Vasc Surg; 2012 Jan; 55(1):105-12. PubMed ID: 21944917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial.
    Karimi A; de Boer SW; van den Heuvel DA; Fioole B; Vroegindeweij D; Heyligers JM; Lohle PN; Elgersma O; Nolthenius RP; Vos JA; de Vries JP
    Trials; 2013 Mar; 14():87. PubMed ID: 23537403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up.
    Donas KP; Torsello G; Schwindt A; Schönefeld E; Boldt O; Pitoulias GA
    J Vasc Surg; 2010 Aug; 52(2):356-61. PubMed ID: 20541349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Drug-Coated Balloon Angioplasty for Isolated Chronic Occlusion of the Popliteal Artery: A Retrospective Single-Institution Study.
    Wu X; Peng Z; Qin J; Yang X; Lu X; Ye K
    J Vasc Interv Radiol; 2021 Apr; 32(4):593-601. PubMed ID: 33531180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of isolated infrapopliteal percutaneous transluminal angioplasty for critical limb ischemia in high-risk diabetic patients.
    Tartaglia E; Lejay A; Georg Y; Roussin M; Thaveau F; Chakfe N
    Vascular; 2016 Oct; 24(5):515-22. PubMed ID: 26603863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.